Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
Axonics recently announced it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) to market the Axonics F15 recharge-free sacral neuromodulation (SNM) system for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback